Oncology Drugs Market Size, Share, Growth, and Industry Analysis, By Type (Chemotherapy, Targeted Therapy, Immunotherapy & Hormonal Therapy), By Application (Blood Cancer, Breast Cancer, and Gastrointestinal Cancer, Prostate Cancer & Respiratory Cancer), and Regional Forecast to 2033

Last Updated: 07 July 2025
SKU ID: 26636035

Detailed TOC of Global Oncology Drugs Market Insights, Forecast to 2033

  1. 1 Report Overview
    1. Study Scope
    2. Market Analysis by Type
      1. Global Oncology Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2033
      2. Chemotherapy
      3. Targeted Therapy
      4. Immunotherapy (Biologic Therapy)
      5. Hormonal Therapy
      6. Others
    3. Market by Application
      1. Global Oncology Drugs Market Growth by Application: 2020 VS 2024 VS 2033
      2. Blood Cancer
      3. Breast Cancer
      4. Gastrointestinal Cancer
      5. Prostate Cancer
      6. Respiratory or Lung Cancer
      7. Others
    4. Study Objectives
    5. Years Considered
    6. Years Considered
  2. Global Growth Trends
    1. Global Oncology Drugs Market Perspective (2020-2033)
    2. Oncology Drugs Growth Trends by Region
      1. Global Oncology Drugs Market Size by Region: 2020 VS 2024 VS 2033
      2. Oncology Drugs Historic Market Size by Region (2020-2024)
      3. Oncology Drugs Forecasted Market Size by Region (2025-2033)
    3. Oncology Drugs Market Dynamics
      1. Oncology Drugs Industry Trends
      2. Oncology Drugs Market Drivers
      3. Oncology Drugs Market Challenges
      4. Oncology Drugs Market Restraints
  3. Competition Landscape by Key Players
    1. Global Top Oncology Drugs Players by Revenue
      1. Global Top Oncology Drugs Players by Revenue (2020-2024)
      2. Global Oncology Drugs Revenue Market Share by Players (2020-2024)
    2. Global Oncology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3. Players Covered: Ranking by Oncology Drugs Revenue
    4. Global Oncology Drugs Market Concentration Ratio
      1. Global Oncology Drugs Market Concentration Ratio (CR5 and HHI)
      2. Global Top 10 and Top 5 Companies by Oncology Drugs Revenue in 2024
    5. Oncology Drugs Key Players Head office and Area Served
    6. Key Players Oncology Drugs Product Solution and Service
    7. Date of Enter into Oncology Drugs Market
    8. Mergers & Acquisitions, Expansion Plans
  4. Oncology Drugs Breakdown Data by Type
    1. Global Oncology Drugs Historic Market Size by Type (2020-2024)
    2. Global Oncology Drugs Forecasted Market Size by Type (2025-2033)
  5. Oncology Drugs Breakdown Data by Application
    1. Global Oncology Drugs Historic Market Size by Application (2020-2024)
    2. Global Oncology Drugs Forecasted Market Size by Application (2025-2033)
  6. North America
    1. North America Oncology Drugs Market Size (2020-2033)
    2. North America Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
    3. North America Oncology Drugs Market Size by Country (2020-2024)
    4. North America Oncology Drugs Market Size by Country (2025-2033)
    5. United States
    6. Canada
  7. Europe
    1. Europe Oncology Drugs Market Size (2020-2033)
    2. Europe Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
    3. Europe Oncology Drugs Market Size by Country (2020-2024)
    4. Europe Oncology Drugs Market Size by Country (2025-2033)
    5. Germany
    6. France
    7. U.K.
    8. Italy
    9. Russia
    10. Nordic Countries
  8. Asia-Pacific
    1. Asia-Pacific Oncology Drugs Market Size (2020-2033)
    2. Asia-Pacific Oncology Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2033
    3. Asia-Pacific Oncology Drugs Market Size by Region (2020-2024)
    4. Asia-Pacific Oncology Drugs Market Size by Region (2025-2033)
    5. China
    6. Japan
    7. South Korea
    8. Southeast Asia
    9. India
    10. Australia
  9. Latin America
    1. Latin America Oncology Drugs Market Size (2020-2033)
    2. Latin America Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
    3. Latin America Oncology Drugs Market Size by Country (2020-2024)
    4. Latin America Oncology Drugs Market Size by Country (2025-2033)
    5. Mexico
    6. Brazil
  10. Middle East & Africa
    1. Middle East & Africa Oncology Drugs Market Size (2020-2033)
    2. Middle East & Africa Oncology Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2033
    3. Middle East & Africa Oncology Drugs Market Size by Country (2020-2024)
    4. Middle East & Africa Oncology Drugs Market Size by Country (2025-2033)
    5. Turkey
    6. Saudi Arabia
    7. UAE
  11. Key Players Profiles
    1. Roche
      1. Roche Company Detail
      2. Roche Business Overview
      3. Roche Oncology Drugs Introduction
      4. Roche Revenue in Oncology Drugs Business (2020-2024)
      5. Roche Recent Development
    2. Celgene
      1. Celgene Company Detail
      2. Celgene Business Overview
      3. Celgene Oncology Drugs Introduction
      4. Celgene Revenue in Oncology Drugs Business (2020-2024)
      5. Celgene Recent Development
    3. Novartis
      1. Novartis Company Detail
      2. Novartis Business Overview
      3. Novartis Oncology Drugs Introduction
      4. Novartis Revenue in Oncology Drugs Business (2020-2024)
      5. Novartis Recent Development
    4. Bristol-Myers Squibb
      1. Bristol-Myers Squibb Company Detail
      2. Bristol-Myers Squibb Business Overview
      3. Bristol-Myers Squibb Oncology Drugs Introduction
      4. Bristol-Myers Squibb Revenue in Oncology Drugs Business (2020-2024)
      5. Bristol-Myers Squibb Recent Development
    5. Johnson & Johnson
      1. Johnson & Johnson Company Detail
      2. Johnson & Johnson Business Overview
      3. Johnson & Johnson Oncology Drugs Introduction
      4. Johnson & Johnson Revenue in Oncology Drugs Business (2020-2024)
      5. Johnson & Johnson Recent Development
    6. Merck & Co.
      1. Merck & Co. Company Detail
      2. Merck & Co. Business Overview
      3. Merck & Co. Oncology Drugs Introduction
      4. Merck & Co. Revenue in Oncology Drugs Business (2020-2024)
      5. Merck & Co. Recent Development
    7. AstraZeneca
      1. AstraZeneca Company Detail
      2. AstraZeneca Business Overview
      3. AstraZeneca Oncology Drugs Introduction
      4. AstraZeneca Revenue in Oncology Drugs Business (2020-2024)
      5. AstraZeneca Recent Development
    8. Pfizer
      1. Pfizer Company Detail
      2. Pfizer Business Overview
      3. Pfizer Oncology Drugs Introduction
      4. Pfizer Revenue in Oncology Drugs Business (2020-2024)
      5. Pfizer Recent Development
    9. Amgen
      1. Amgen Company Detail
      2. Amgen Business Overview
      3. Amgen Oncology Drugs Introduction
      4. Amgen Revenue in Oncology Drugs Business (2020-2024)
      5. Amgen Recent Development
    10. Eli Lilly
      1. Eli Lilly Company Detail
      2. Eli Lilly Business Overview
      3. Eli Lilly Oncology Drugs Introduction
      4. Eli Lilly Revenue in Oncology Drugs Business (2020-2024)
      5. Eli Lilly Recent Development
    11. AbbVie
      1. AbbVie Company Detail
      2. AbbVie Business Overview
      3. AbbVie Oncology Drugs Introduction
      4. AbbVie Revenue in Oncology Drugs Business (2020-2024)
      5. AbbVie Recent Development
    12. Takeda
      1. Takeda Company Detail
      2. Takeda Business Overview
      3. Takeda Oncology Drugs Introduction
      4. Takeda Revenue in Oncology Drugs Business (2020-2024)
      5. Takeda Recent Development
    13. Astellas
      1. Astellas Company Detail
      2. Astellas Business Overview
      3. Astellas Oncology Drugs Introduction
      4. Astellas Revenue in Oncology Drugs Business (2020-2024)
      5. Astellas Recent Development
    14. Ipsen
      1. Ipsen Company Detail
      2. Ipsen Business Overview
      3. Ipsen Oncology Drugs Introduction
      4. Ipsen Revenue in Oncology Drugs Business (2020-2024)
      5. Ipsen Recent Development
    15. Sanofi
      1. Sanofi Company Detail
      2. Sanofi Business Overview
      3. Sanofi Oncology Drugs Introduction
      4. Sanofi Revenue in Oncology Drugs Business (2020-2024)
      5. Sanofi Recent Development
    16. Bayer
      1. Bayer Company Detail
      2. Bayer Business Overview
      3. Bayer Oncology Drugs Introduction
      4. Bayer Revenue in Oncology Drugs Business (2020-2024)
      5. Bayer Recent Development
    17. Biogen Idec
      1. Biogen Idec Company Detail
      2. Biogen Idec Business Overview
      3. Biogen Idec Oncology Drugs Introduction
      4. Biogen Idec Revenue in Oncology Drugs Business (2020-2024)
      5. Biogen Idec Recent Development
    18. Teva
      1. Teva Company Detail
      2. Teva Business Overview
      3. Teva Oncology Drugs Introduction
      4. Teva Revenue in Oncology Drugs Business (2020-2024)
      5. Teva Recent Development
    19. Otsuka
      1. Otsuka Company Detail
      2. Otsuka Business Overview
      3. Otsuka Oncology Drugs Introduction
      4. Otsuka Revenue in Oncology Drugs Business (2020-2024)
      5. Otsuka Recent Development
    20. Eisai
      1. Eisai Company Detail
      2. Eisai Business Overview
      3. Eisai Oncology Drugs Introduction
      4. Eisai Revenue in Oncology Drugs Business (2020-2024)
      5. Eisai Recent Development
    21. Merck KGaA
      1. Merck KGaA Company Detail
      2. Merck KGaA Business Overview
      3. Merck KGaA Oncology Drugs Introduction
      4. Merck KGaA Revenue in Oncology Drugs Business (2020-2024)
      5. Merck KGaA Recent Development
    22. Gilead Sciences
      1. Gilead Sciences Company Detail
      2. Gilead Sciences Business Overview
      3. Gilead Sciences Oncology Drugs Introduction
      4. Gilead Sciences Revenue in Oncology Drugs Business (2020-2024)
      5. Gilead Sciences Recent Development
  12. Analyst's Viewpoints/Conclusions
  13. Appendix
    1. Research Methodology
      1. Methodology/Research Approach
      2. Data Source
    2. Disclaimer
    3. Author Details